1h Free Analyst Time
The biosimulation market is forecasted to grow by USD 4.74 billion during 2023-2028, accelerating at a CAGR of 18.52% during the forecast period. The report on the biosimulation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in research funding and grants, rising demand for personalized medicine, and strategic initiatives by vendors.
The biosimulation market is segmented as below:
By End-user
- Pharmaceuticals and biotechnology companies
- Contract research and organizations
- Others
By Product
- Software
- Services
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the biosimulation market covers the following areas:
- Biosimulation market sizing
- Biosimulation market forecast
- Biosimulation market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global biosimulation market: Advanced Chemistry Development Inc., Allucent, Altair Engineering Inc., ANSYS Inc., Applied BioMath LLC., Cellworks Group Inc., Certara Inc., Chemical Computing Group ULC, Dassault Systemes SE, Genedata AG, INOSIM Software GmbH, Intelligen Inc., LifeTec Group, Physiomics Plc, Rosa and Co. LLC, Schrodinger Inc., Simulations Plus Inc., Thermo Fisher Scientific Inc., Via Science Inc., and Yokogawa Electric Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is implementation of big data using mathematical models and simulation for drug discovery."
According to the report, one of the major drivers for this market is the increase in research funding and grants.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Chemistry Development Inc.
- Allucent
- Altair Engineering Inc.
- ANSYS Inc.
- Applied BioMath LLC.
- Cellworks Group Inc.
- Certara Inc.
- Chemical Computing Group ULC
- Dassault Systemes SE
- Genedata AG
- INOSIM Software GmbH
- Intelligen Inc.
- LifeTec Group
- Physiomics Plc
- Rosa and Co. LLC
- Schrodinger Inc.
- Simulations Plus Inc.
- Thermo Fisher Scientific Inc.
- Via Science Inc.
- Yokogawa Electric Corp.
